Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells

MW Verghese, RT McConnell, JM Lenhard, L Hamacher and SL Jin

Department of Cell Biology, Glaxo Inc. Research Institute, Research Triangle Park, North Carolina 27709, USA.

Many functions of the immune and inflammatory responses are inhibited by agents that increase intracellular levels of cAMP. Recent investigations have revealed that cAMP levels in inflammatory cells are regulated by cyclic nucleotide phosphodiesterases (PDEs) belonging to the PDE4 family (cAMP-specific PDEs). At least four different genes are known to encode PDE4 isozymes, which are characterized by their selectivity for cAMP over cGMP and their sensitivity to the antidepressant drug rolipram. The aim of our studies was to investigate whether monocytic cells could regulate PDE4 activity and whether certain PDE4 isozymes were expressed preferentially over others. Our results showed that treatment of peripheral blood monocytes or closely related Mono Mac 6 cells with dibutyryl-cAMP or other cAMP-elevating agents transiently increased rolipram-sensitive PDE4 activity 2-3-fold, without concomitant increases in cGMP-inhibited PDE (PDE3) activity. PDE4 activity was predominantly cytosolic, whereas PDE3 activity was localized to the particulate fraction. Our Northern and Western blot studies with reagents recognizing three distinct PDE4 gene products (PDE4A, PDE4B, and PDE4D) revealed that their expression is transcriptionally regulated in monocytic cells. Although none of the three isozymes was detectable under normal culture conditions, all of these were up-regulated when Mono Mac 6 cells were exposed to dibutyryl- cAMP. Distinct differences were observed in their temporal patterns of expression. Endotoxin lipopolysaccharide, a potent monocyte stimulus, also enhanced PDE4 activity in monocytic cells. These data indicate that monocytic cells may express different PDE4 isozymes, depending on their state of activation or differentiation. These isozymes could thus regulate intracellular cAMP levels at various stages of monocyte activation and could thereby be important in limiting the inflammatory response.

Volume 47, Issue 6, pp. 1164-1171, 06/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				T. Klein, M. Eltze, T. Grebe, A. Hatzelmann, and M. Komhoff Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition Cardiovasc Res, July 15, 2007; 75(2): 390 - 397. [Abstract] [Full Text] [PDF]

				M. A. Giembycz and R. Newton Beyond the dogma: novel {beta}2-adrenoceptor signalling in the airways. Eur. Respir. J., June 1, 2006; 27(6): 1286 - 1306. [Abstract] [Full Text] [PDF]

				H. Park, J.-A Lee, C. Lee, M.-J. Kim, D.-J. Chang, H. Kim, S.-H. Lee, Y.-S. Lee, and B.-K. Kaang An Aplysia Type 4 Phosphodiesterase Homolog Localizes at the Presynaptic Terminals of Aplysia Neuron and Regulates Synaptic Facilitation J. Neurosci., September 28, 2005; 25(39): 9037 - 9045. [Abstract] [Full Text] [PDF]

				D. G. Tilley and D. H. Maurice Vascular Smooth Muscle Cell Phenotype-Dependent Phosphodiesterase 4D Short Form Expression: Role of Differential Histone Acetylation on cAMP-Regulated Function Mol. Pharmacol., September 1, 2005; 68(3): 596 - 605. [Abstract] [Full Text] [PDF]

				S.-L. C. Jin, L. Lan, M. Zoudilova, and M. Conti Specific Role of Phosphodiesterase 4B in Lipopolysaccharide-Induced Signaling in Mouse Macrophages J. Immunol., August 1, 2005; 175(3): 1523 - 1531. [Abstract] [Full Text] [PDF]

				P. G. Smith, F. Wang, K. N. Wilkinson, K. J. Savage, U. Klein, D. S. Neuberg, G. Bollag, M. A. Shipp, and R. C. T. Aguiar The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma Blood, January 1, 2005; 105(1): 308 - 316. [Abstract] [Full Text] [PDF]

				A. L. Asirvatham, S. G. Galligan, R. V. Schillace, M. P. Davey, V. Vasta, J. A. Beavo, and D. W. Carr A-Kinase Anchoring Proteins Interact with Phosphodiesterases in T Lymphocyte Cell Lines J. Immunol., October 15, 2004; 173(8): 4806 - 4814. [Abstract] [Full Text] [PDF]

				S. Oger, C. Mehats, E. Dallot, F. Ferre, and M.-J. Leroy Interleukin-1{beta} Induces Phosphodiesterase 4B2 Expression in Human Myometrial Cells through a Prostaglandin E2- and Cyclic Adenosine 3',5'-Monophosphate-Dependent Pathway J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5524 - 5531. [Abstract] [Full Text] [PDF]

				D. Burzyn, C. C. Jancic, S. Zittermann, M. I. Keller Sarmiento, L. Fainboim, R. E. Rosenstein, and H. E. Chuluyan Decrease in cAMP levels modulates adhesion to fibronectin and immunostimulatory ability of human dendritic cells J. Leukoc. Biol., July 1, 2002; 72(1): 93 - 100. [Abstract] [Full Text] [PDF]

				S.-L. C. Jin and M. Conti Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses PNAS, May 28, 2002; 99(11): 7628 - 7633. [Abstract] [Full Text] [PDF]

				L. Persani, S. Borgato, A. Lania, M. Filopanti, G. Mantovani, M. Conti, and A. Spada Relevant cAMP-Specific Phosphodiesterase Isoforms in Human Pituitary: Effect of Gs{alpha} Mutations J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3795 - 3800. [Abstract] [Full Text] [PDF]

				L. Persani, A. Lania, L. Alberti, R. Romoli, G. Mantovani, S. Filetti, A. Spada, and M. Conti Induction of Specific Phosphodiesterase Isoforms by Constitutive Activation of the cAMP Pathway in Autonomous Thyroid Adenomas J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2872 - 2878. [Abstract] [Full Text]

				B. Bielekova, A. Lincoln, H. McFarland, and R. Martin Therapeutic Potential of Phosphodiesterase-4 and -3 Inhibitors in Th1-Mediated Autoimmune Diseases J. Immunol., January 15, 2000; 164(2): 1117 - 1124. [Abstract] [Full Text] [PDF]

				C. Méhats, G. Tanguy, E. Dallot, B. Robert, R. Rebourcet, F. Ferré, and M. J. Leroy Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture Endocrinology, July 1, 1999; 140(7): 3228 - 3237. [Abstract] [Full Text]

				L. G. Corral, P. A. J. Haslett, G. W. Muller, R. Chen, L.-M. Wong, C. J. Ocampo, R. T. Patterson, D. I. Stirling, and G. Kaplan Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-{alpha} J. Immunol., July 1, 1999; 163(1): 380 - 386. [Abstract] [Full Text] [PDF]

				H. Liu and D. H. Maurice Phosphorylation-mediated Activation and Translocation of the Cyclic AMP-specific Phosphodiesterase PDE4D3 by Cyclic AMP-dependent Protein Kinase and Mitogen-activated Protein Kinases. A POTENTIAL MECHANISM ALLOWING FOR THE COORDINATED REGULATION OF PDE4D ACTIVITY AND TARGETING J. Biol. Chem., April 9, 1999; 274(15): 10557 - 10565. [Abstract] [Full Text] [PDF]

				M. Takahashi, R. Terwilliger, C. Lane, P. S. Mezes, M. Conti, and R. S. Duman Chronic Antidepressant Administration Increases the Expression of cAMP-Specific Phosphodiesterase 4A and 4B Isoforms J. Neurosci., January 15, 1999; 19(2): 610 - 618. [Abstract] [Full Text] [PDF]

				D. Ma, P. Wu, R. W. Egan, M. M. Billah, and P. Wang Phosphodiesterase 4B Gene Transcription Is Activated by Lipopolysaccharide and Inhibited by Interleukin-10 in Human Monocytes Mol. Pharmacol., January 1, 1999; 55(1): 50 - 57. [Abstract] [Full Text]

				L. C. Wright, J. Seybold, A. Robichaud, I. M. Adcock, and P. J. Barnes Phosphodiesterase expression in human epithelial cells Am J Physiol Lung Cell Mol Physiol, October 1, 1998; 275(4): L694 - L700. [Abstract] [Full Text] [PDF]

				J. Seybold, R. Newton, L. Wright, P. A. Finney, N. Suttorp, P. J. Barnes, I. M. Adcock, and M. A. Giembycz Induction of Phosphodiesterases 3B, 4A4, 4D1, 4D2, and 4D3 in Jurkat T-cells and in Human Peripheral Blood T-lymphocytes by 8-Bromo-cAMP and Gs-coupled Receptor Agonists. POTENTIAL ROLE IN beta 2-ADRENORECEPTOR DESENSITIZATION J. Biol. Chem., August 7, 1998; 273(32): 20575 - 20588. [Abstract] [Full Text] [PDF]

				S. Iona, M. Cuomo, T. Bushnik, F. Naro, C. Sette, M. Hess, E. R. Shelton, and M. Conti Characterization of the Rolipram-Sensitive, Cyclic AMP-Specific Phosphodiesterases: Identification and Differential Expression of Immunologically Distinct Forms in the Rat Brain Mol. Pharmacol., January 1, 1998; 53(1): 23 - 32. [Abstract] [Full Text]

				E. Vicini and M. Conti Characterization of an Intronic Promoter of a Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Specific Phosphodiesterase Gene that Confers Hormone and cAMP Inducibility Mol. Endocrinol., June 1, 1997; 11(7): 839 - 850. [Abstract] [Full Text]

				T. J. TORPHY Phosphodiesterase Isozymes . Molecular Targets for Novel Antiasthma Agents Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 351 - 370. [Full Text]

				C. P. NIELSON and N. E. HADJOKAS Beta-Adrenoceptor Agonists Block Corticosteroid Inhibition in Eosinophils Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 184 - 191. [Abstract] [Full Text]

				E. Huston, L. Pooley, P. Julien, G. Scotland, I. McPhee, M. Sullivan, G. Bolger, and M. D. Houslay The Human Cyclic AMP-specific Phosphodiesterase PDE-46 (HSPDE4A4B) Expressed in Transfected COS7 Cells Occurs as Both Particulate and Cytosolic Species That Exhibit Distinct Kinetics of Inhibition by the Antidepressant Rolipram J. Biol. Chem., December 6, 1996; 271(49): 31334 - 31344. [Abstract] [Full Text] [PDF]

				C. Sette and M. Conti Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein Kinase. INVOLVEMENT OF SERINE 54IN THE ENZYME ACTIVATION J. Biol. Chem., July 12, 1996; 271(28): 16526 - 16534. [Abstract] [Full Text] [PDF]

				T. J. Torphy, H.-L. Zhou, J. J. Foley, H. M. Sarau, C. D. Manning, and M. S. Barnette Salbutamol Up-regulates PDE4 Activity and Induces a Heterologous Desensitization of U937 Cells to Prostaglandin E(2) J. Biol. Chem., October 6, 1995; 270(40): 23598 - 23604. [Abstract] [Full Text] [PDF]

				H. Liu, D. Palmer, S. L. Jimmo, D. G. Tilley, H. A. Dunkerley, S. C. Pang, and D. H. Maurice Expression of Phosphodiesterase 4D (PDE4D) Is Regulated by Both the Cyclic AMP-dependent Protein Kinase and Mitogen-activated Protein Kinase Signaling Pathways. A POTENTIAL MECHANISM ALLOWING FOR THE COORDINATED REGULATION OF PDE4D ACTIVITY AND EXPRESSION IN CELLS J. Biol. Chem., August 18, 2000; 275(34): 26615 - 26624. [Abstract] [Full Text] [PDF]